GoldBamboo.com - Knowledge is strong medicine
  

Impact of nCPAP Treatment on Liver Function in Patients with Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis - Article


  Not Signed In - Sign In / Register






Sleep Apnea

Apnea; Apnea, Sleep


Clinical Trial: Impact of nCPAP Treatment on Liver Function in Patients with Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis

This study is currently recruiting patients.
Verified by University Hospital Angers September 2005

Sponsored by: University Hospital Angers
Information provided by: University Hospital Angers
ClinicalTrials.gov Identifier: NCT00152711

Purpose

This study aims to evaluate the impact of nCPAP treatment on liver enzymes in patients with sleep apnea syndrome and nonalcoholic steatohepatitis. Using a cross over design, the evolution of liver enzymes will be evaluate in 40 patients during to consecutive periodes of 6 weeks, with and without nCPAP treatment.
Condition Intervention
Sleep Apnea Syndrome
Nonalcoholic steatohepatitis
 Device: nCPAP

MedlinePlus related topics:  Sleep Apnea

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Uncontrolled, Expanded Access Assignment

Official Title: Impact of nCPAP Treatment on Liver Function in Patients with Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis: a Prospective Cross Over Trial.

Further Study Details: 

Expected Total Enrollment:  40

Study start: September 2004

Eligibility

Ages Eligible for Study:  18 Years   -   70 Years,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

18 to 70 years old Nonalcoholic steatohepatitis proven by liver biopsy Sleep apnea syndrome proven by polysomnography with an apnea-hypopnea index > 10 events/h Informed consent

Exclusion Criteria:

Psychiatric disorder Other cause of liver disease Professional driver

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00152711

Frédéric Gagnadoux, MD      33(0)241353695    frgagnadoux@chu-angers.fr

Study chairs or principal investigators

Frédéric Gagnadoux,  Principal Investigator,  UH Angers   

More Information

Study ID Numbers:  PHRC 03-07
Last Updated:  September 8, 2005
Record first received:  September 8, 2005
ClinicalTrials.gov Identifier:  NCT00152711
Health Authority: France: French General Health Administration
ClinicalTrials.gov processed this record on 2005-09-13


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Sleep Apnea.

May 15, 2008



Page Updated: May 11, 2006
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2007 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.